Work

Outcomes based on treatment regimen in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer receiving intravenous or intraperitoneal platinum-based chemotherapy in combination with veliparib and bevacizumab

Year: 2020

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2020.06.030

Authors: C.R. Washington, A. Miller, K.N. Moore, K.M. Bell-McGuinn, R. Schilder, J.L. Walker, W.E. Brady, R.E. O'Cearbhaill, S.R. Guntupalli, D.K. Armstrong, A.R. Hagemann, H.J. Gray, L.R. Duska, C.A. Mathews, A. Chen, D.M. O'Malley, S.W. Gordon, C. Aghajanian

Institutions: University of Oklahoma Health Sciences Center, OU Health Stephenson Cancer Center, Memorial Sloan Kettering Cancer Center, Thomas Jefferson University, University of Oklahoma, University of Colorado Denver, Sidney Kimmel Comprehensive Cancer Center, Washington University in St. Louis, University of Washington Medical Center, University of Virginia, Brown University, National Institutes of Health, National Cancer Institute, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Virginia Commonwealth University

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3095702098

FWCI:

Cites:

Cited by:

Related to: 10